In the context of histology, triple negative refers to a subtype of breast cancer that does not express the genes for estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). This classification is crucial as it guides the treatment strategy and prognosis for the patient.
